Franssen, L.E.; Stege, C.A.M.; Zweegman, S.; van de Donk, N.W.C.J.; Nijhof, I.S.
Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma. J. Clin. Med. 2020, 9, 1195.
https://doi.org/10.3390/jcm9041195
AMA Style
Franssen LE, Stege CAM, Zweegman S, van de Donk NWCJ, Nijhof IS.
Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma. Journal of Clinical Medicine. 2020; 9(4):1195.
https://doi.org/10.3390/jcm9041195
Chicago/Turabian Style
Franssen, Laurens E., Claudia A. M. Stege, Sonja Zweegman, Niels W. C. J. van de Donk, and Inger S. Nijhof.
2020. "Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma" Journal of Clinical Medicine 9, no. 4: 1195.
https://doi.org/10.3390/jcm9041195
APA Style
Franssen, L. E., Stege, C. A. M., Zweegman, S., van de Donk, N. W. C. J., & Nijhof, I. S.
(2020). Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma. Journal of Clinical Medicine, 9(4), 1195.
https://doi.org/10.3390/jcm9041195